Cargando…

Lower Levels of Transaminases but Higher Levels of Serum Creatinine in Patients with Acute Hepatitis E in Comparison to Patients with Hepatitis A

In patients with hepatitis E virus (HEV) infections, extrahepatic, particularly renal and hematological manifestations, are increasingly reported in the medical literature but have never been studied compared to a control cohort. We retrospectively analyzed medical records of consecutive patients th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brehm, Thomas Theo, Mazaheri, Omid, Horvatits, Thomas, Lütgehetmann, Marc, Schulze zur Wiesch, Julian, Lohse, Ansgar W., Polywka, Susanne, Pischke, Sven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826713/ https://www.ncbi.nlm.nih.gov/pubmed/33445435 http://dx.doi.org/10.3390/pathogens10010060

Ejemplares similares

The Clinical Perspective on Hepatitis E
por: Horvatits, Thomas, et al.
Publicado: (2019)

Significance of Anti-Nuclear Antibodies and Cryoglobulins in Patients with Acute and Chronic HEV Infection
por: Horvatits, Thomas, et al.
Publicado: (2020)

New foe treated with old guns – supportive role of steroids in the treatment of acute severe hepatitis E
por: Sebode, Marcial, et al.
Publicado: (2014)

Clinical features of hepatitis E infections in patients with hematologic disorders
por: Ghandili, Susanne, et al.
Publicado: (2022)

Non-organ-specific autoantibodies with unspecific patterns are a frequent para-infectious feature of chronic hepatitis D
por: Hermanussen, Lennart, et al.
Publicado: (2023)

Transjugular Intrahepatic Portosystemic Shunt: A Possible Risk Factor for Direct‐Acting Antiviral Treatment Failure in Patients With Hepatitis C?
por: Piecha, Felix, et al.
Publicado: (2019)

Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients
por: Gömer, André, et al.
Publicado: (2023)

SARS‐CoV‐2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease
por: Duengelhoef, Paul, et al.
Publicado: (2022)

Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic
por: Brehm, Thomas Theo, et al.
Publicado: (2021)

Sotrovimab in Hospitalized Patients with SARS-CoV-2 Omicron Variant Infection: a Propensity Score-Matched Retrospective Cohort Study
por: Woo, Marcel S., et al.
Publicado: (2022)

Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients
por: Pflüger, Lisa Sophie, et al.
Publicado: (2020)

Performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease with and without morbid obesity
por: Drolz, Andreas, et al.
Publicado: (2021)

Erratum zu: Milde COVID-19-Verläufe bei Mitarbeitenden einer Universitätsklinik: Die „erste Welle“ am Universitätsklinikum Hamburg-Eppendorf
por: von Felden, Johann, et al.
Publicado: (2021)

Milde COVID-19-Verläufe bei Mitarbeitenden einer Universitätsklinik: Die „erste Welle“ am Universitätsklinikum Hamburg-Eppendorf
por: von Felden, Johann, et al.
Publicado: (2021)

Low incidence of COVID-19 in a prospective cohort of patients with liver cirrhosis and hepatocellular carcinoma treated at a tertiary medical center during the 2020 pandemic
por: Fründt, Thorben, et al.
Publicado: (2021)

Three Separate Spike Antigen Exposures by COVID-19 Vaccination or SARS-CoV-2 Infection Elicit Strong Humoral Immune Responses in Healthcare Workers
por: Brehm, Thomas Theo, et al.
Publicado: (2022)

High Rates of Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Metabolic and Cardiovascular Comorbidities
por: Bockmann, Jan-Hendrik, et al.
Publicado: (2021)

Risk factors for worsening of somatic symptom burden in a prospective cohort during the COVID-19 pandemic
por: Engelmann, Petra, et al.
Publicado: (2022)

Hepatitis E Virus infection in HIV-infected patients with elevated serum transaminases levels
por: Sellier, Pierre, et al.
Publicado: (2011)

Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute Plasmodium falciparum Malaria: LAG-3 and TIM-3 Correlate With T Cell Activation and Course of Disease
por: Herrmann, Marissa, et al.
Publicado: (2020)

Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study
por: Brehm, Thomas Theo, et al.
Publicado: (2021)

Assessment of fibrotic burden among chronic hepatitis B virus-infected patients with normal transaminase level
por: Jeon, Mi Young, et al.
Publicado: (2018)

Influence of Alanine Transaminase Levels on Alpha-Fetoprotein for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Infection
por: Chen, Jiahao, et al.
Publicado: (2020)

Hepatitis E: Still Waters Run Deep
por: von Wulffen, Moritz, et al.
Publicado: (2017)

Lymphocytopenia and Anti-CD38 Directed Treatment Impact the Serological SARS-CoV-2 Response after Prime Boost Vaccination in Patients with Multiple Myeloma
por: Ghandili, Susanne, et al.
Publicado: (2021)

Human hepatitis D virus-specific T cell epitopes
por: Kohsar, Matin, et al.
Publicado: (2021)

Highly sensitive nucleic acid detection and transaminase level in treatment decisions for Chinese patients with cirrhosis caused by hepatitis
por: Zhang, Yue-Rong, et al.
Publicado: (2020)

Effect of Non-alcoholic Fatty Liver Disease on Transaminase Levels and Transient Elastography in Patients with Chronic Hepatitis B
por: Sharif, Asim, et al.
Publicado: (2019)

Frequent detection of functional hyposplenism via assessment of pitted erythrocytes in patients with advanced liver cirrhosis
por: Wehmeyer, Malte H., et al.
Publicado: (2022)

Higher Responsiveness for Women, High Transaminase Levels, and Fat Percentage to Pemafibrate Treatment for NAFLD
por: Iwadare, Takanobu, et al.
Publicado: (2022)

Diagnostic accuracy of liver stiffness measurement in chronic hepatitis B patients with normal or mildly elevated alanine transaminase levels
por: Li, Qiang, et al.
Publicado: (2018)

SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients
por: Ruether, Darius F., et al.
Publicado: (2022)

Serum hepatitis B surface antigen levels predict insignificant fibrosis and non-cirrhosis in hepatitis B e antigen positive patients with normal or mildly elevated alanine transaminase levels
por: Li, Qiang, et al.
Publicado: (2017)

Extrahepatic manifestations and HEV, the genotype matters
por: Horvatits, Thomas, et al.
Publicado: (2018)

Safety and efficacy of elvitegravir, dolutegravir, and raltegravir in a real-world cohort of treatment-naïve and -experienced patients
por: Brehm, Thomas Theo, et al.
Publicado: (2019)

Occult Hepatitis B Virus Among the Patients With Abnormal Alanine Transaminase
por: Makvandi, Manoochehr, et al.
Publicado: (2014)

Absence of self-reported neuropsychiatric and somatic symptoms after Omicron variant SARS-CoV-2 breakthrough infections
por: Woo, Marcel S, et al.
Publicado: (2023)

Higher Risk of HEV Transmission and Exposure among Blood Donors in Europe and Asia in Comparison to North America: A Meta-Analysis
por: Wolski, Annika, et al.
Publicado: (2023)

SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies
por: Brehm, Thomas Theo, et al.
Publicado: (2021)

Prognostic Value of Aspartate Transaminase/Alanine Transaminase Ratio in Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma Undergoing Hepatectomy
por: Mo, Qiuyan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_75d3e0f7nj14214rd1uq0dcs8p